(Reuters) -London’s FTSE 100 ended higher on Thursday on the back of gains in healthcare heavyweight GlaxoSmithKline and mining stocks, while hopes of a faster economic recovery lifted the mid-cap index to record highs.
FILE PHOTO: The London Stock Exchange Group offices are seen in the City of London, Britain, December 29, 2017.
REUTERS/Toby MelvilleThe blue-chip index rose 0.6%, with GlaxoSmithKline advancing 5% to become the top gainer after the European Medicines Agency said it was reviewing available data on the use of the company’s monoclonal antibody to treat COVID-19 patients.
Precious and base metal miners added 2.6% and 1.3%, respectively, as they benefited from higher metal and gold prices.
British gambling group Entain gained 1.1% after its quarterly online net revenue jumped 33%, even as shop closures hit its total net gaming revenue.
Toby Melville, ”, Michael Hewson, Travis Perkins
Reuters, GlaxoSmithKline, London Stock Exchange Group, City of, REUTERS, European Medicines Agency, Management, CMC Markets, Wickes
City, City of London, Britain, U.S, British